TAIM
ABBV icon

Te Ahumairangi Investment Management’s AbbVie ABBV Stock Holding History

Te Ahumairangi Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.96M Buy
22,818
+2,450
+12% +$543K 0.83% 44
2025
Q4 		$4.65M Sell
20,368
-2,282
-10% -$520K 0.83% 45
2025
Q3 		$5.24M Sell
22,650
-1,180
-5% -$240K 0.89% 40
2025
Q2 		$4.42M Buy
23,830
+3,190
+15% +$593K 0.79% 49
2025
Q1 		$4.32M Sell
20,640
-2,432
-11% -$473K 0.92% 44
2024
Q4 		$4.1M Buy
23,072
+1,010
+5% +$186K 0.86% 51
2024
Q3 		$4.33M Sell
22,062
-90
-0.4% -$16.8K 0.77% 54
2024
Q2 		$3.8M Sell
22,152
-380
-2% -$62.9K 0.73% 52
2024
Q1 		$4.1M Buy
22,532
+525
+2% +$90.5K 0.71% 52
2023
Q4 		$3.41M Buy
22,007
+750
+4% +$109K 0.65% 57
2023
Q3 		$3.17M Sell
21,257
-9,910
-32% -$1.45M 0.52% 65
2023
Q2 		$4.2M Buy
31,167
+5,825
+23% +$854K 0.57% 66
2023
Q1 		$4.04M Buy
25,342
+7,145
+39% +$1.09M 0.58% 66
2022
Q4 		$2.94M Sell
18,197
-1,200
-6% -$184K 0.46% 70
2022
Q3 		$2.6M Buy
19,397
+95
+0.5% +$13.6K 0.44% 70
2022
Q2 		$2.96M Sell
19,302
-2,746
-12% -$420K 0.45% 71
2022
Q1 		$3.57M Sell
22,048
-55,129
-71% -$8.01M 0.49% 72
2021
Q4 		$10.4M Sell
77,177
-6,300
-8% -$744K 1.35% 24
2021
Q3 		$9.01M Sell
83,477
-352
-0.4% -$40.2K 1.24% 27
2021
Q2 		$9.44M Hold
83,829
– – 1.23% 27
2021
Q1 		$9.07M Buy
83,829
+4,000
+5% +$428K 1.16% 31
2020
Q4 		$8.55M Buy
79,829
+5,600
+8% +$538K 1.19% 29
2020
Q3 		$6.5M Buy
+74,229
New +$6.99M 1.11% 30

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Te Ahumairangi Investment Management's ABBV Position: Q1 2026 in Review

Te Ahumairangi Investment Management increased its AbbVie (ABBV) stake by 12% in Q1 2026, buying an estimated $543K and bringing the position to 22,818 shares worth $4.96M. The position accounts for 0.83% of the portfolio, ranked #44.

Te Ahumairangi Investment Management first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $10.4M in Q4 2021. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Te Ahumairangi Investment Management held 22,818 shares of AbbVie worth $4.96M as of Q1 2026.
  • Te Ahumairangi Investment Management bought 2,450 AbbVie shares in Q1 2026, an estimated $543K.
  • AbbVie made up 0.83% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #44 holding.
  • Te Ahumairangi Investment Management first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's AbbVie position peaked at $10.4M in Q4 2021.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.